Want to see MIR full AI Analyst Report?
MIR Stock Chart & Stats
$19.72
-$0.41(-2.41%)
At close: 4:00 PM EST
$19.72
-$0.41(-2.41%)
Day’s Range― - ―
52-Week Range$15.58 - $30.28
Previous CloseN/A
Volume292.68K
Average Volume (3M)4.05M
Market Cap
$4.49B
Enterprise Value$5.15B
Total Cash (Recent Filing)$404.90M
Total Debt (Recent Filing)$1.23B
Price to Earnings (P/E)170.4
Beta1.56
Next Earnings
Jul 30, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.11
Shares Outstanding244,655,720
10 Day Avg. Volume3,869,729
30 Day Avg. Volume4,045,220
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)2.89
Price to Sales (P/S)5.82
P/FCF Ratio50.38
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue5.25
Enterprise Value/Gross Profit11.17
Enterprise Value/Ebitda25.67
Forecast
1Y Price Target
$28.00Price Target Upside41.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.54
Revenue Forecast (FY)$1.14B
Bulls Say, Bears Say
Bulls Say
Acquisition-driven Recurring RevenueThe Paragon acquisition provides stable, recurring demand tied to U.S. fleet modernization, strengthening revenue visibility and recurring service opportunities.
Margins & ProductivityManagement expects margin improvement from operating leverage, procurement gains, and AI-driven productivity initiatives, which could drive higher profitability as acquisition integrations become margin-neutral and then accretive.
Nuclear Market TailwindsGrowing demand for reactor replacements, life-extension work and new projects, supported by shifting public perception and increased data center power needs, bolsters long-term demand for radiation testing and monitoring solutions.
Bears Say
Earnings VolatilityTiming of large awards and order recognition can produce quarter-to-quarter swings in reported results, increasing short-term earnings uncertainty for the stock.
Guidance And Valuation PressureEarnings guidance that fell below analyst expectations, combined with a premium valuation, means clearer evidence of sustained growth is likely needed before the stock can re-rate upward.
Segment-specific Demand WeaknessOrganic sales weakness in Labs & Research and radiological testing quality assurance segments could limit top-line momentum if those end markets remain soft.
Mirion Technologies News
MIR FAQ
What was Mirion Technologies, Inc.’s price range in the past 12 months?
Mirion Technologies, Inc. lowest stock price was $15.58 and its highest was $30.28 in the past 12 months.
What is Mirion Technologies, Inc.’s market cap?
Mirion Technologies, Inc.’s market cap is $4.49B.
When is Mirion Technologies, Inc.’s upcoming earnings report date?
Mirion Technologies, Inc.’s upcoming earnings report date is Jul 30, 2026 which is in 28 days.
How were Mirion Technologies, Inc.’s earnings last quarter?
Mirion Technologies, Inc. released its earnings results on Apr 28, 2026. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of $0.095 by $0.005.
Is Mirion Technologies, Inc. overvalued?
According to Wall Street analysts Mirion Technologies, Inc.’s price is currently Undervalued.
Does Mirion Technologies, Inc. pay dividends?
Mirion Technologies, Inc. does not currently pay dividends.
What is Mirion Technologies, Inc.’s EPS estimate?
Mirion Technologies, Inc.’s EPS estimate is 0.1.
How many shares outstanding does Mirion Technologies, Inc. have?
Mirion Technologies, Inc. has 244,655,720 shares outstanding.
What happened to Mirion Technologies, Inc.’s price movement after its last earnings report?
Mirion Technologies, Inc. reported an EPS of $0.1 in its last earnings report, beating expectations of $0.095. Following the earnings report the stock price went down -0.107%.
Which hedge fund is a major shareholder of Mirion Technologies, Inc.?
Currently, no hedge funds are holding shares in MIR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Mirion Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$28.00 (41.99% Upside)
$28.00 (41.99% Upside)
Blogger Sentiment
Bullish
MIR Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 58.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $165.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 5.7%
Last 30 Days ▲ 5.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.72%
12-Months-Change
Fundamentals
Return on Equity
1.43%
Trailing 12-Months
Asset Growth
34.67%
Trailing 12-Months
Company Description
Mirion Technologies, Inc.
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
MIR Company Deck
MIR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong commercial momentum driven by large order growth, a materially expanded backlog, robust contributions from the Paragon and CertRec acquisitions, and sustained improvement in core end markets (notably nuclear power, SMRs, and Medical RTQA). Financial performance showed healthy revenue (+28%) and adjusted EBITDA (+16%) growth, with management maintaining full-year guidance and forecasting stronger sequential orders. Near-term headwinds were primarily margin dilution from recent M&A, seasonal and timing-related cash flow weakness, and some regional/new-build softness in Asia, but these were framed as manageable and addressable through integration synergies, operational improvements, and expected cash conversion later in the year. Overall, positive operational and market developments materially outweigh the transitory challenges described.View all MIR earnings summariesMIR Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$28.00
▲(41.99% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
4.44% Insiders
32.61% Mutual Funds
31.06% Other Institutional Investors
2.37% Public Companies and
Individual Investors







